The beginning of Sun Pharma’s diversification out of generic drugs is here and it’s a drug that MSD, known as Merck in North America, was happy to pass over to the Indian pharma company. The drug is Ilumya and it’s a treatment for moderate-to-severe plaque psoriasis.
Ook interessant voor je
Reageer